Sep 12, 2023

Proton pump inhibitor use linked to increased fatigue in kidney transplant recipients

Posted by in categories: biotech/medical, health, neuroscience

Netherlands: The use of proton pump inhibitors (PPI) among kidney transplant recipients may lead to severe fatigue, fatigue severity, and lower mental and physical health-related quality of life, a new study has suggested. The study was published online in the American Journal Of Kidney Diseases.

Proton pump inhibitors (PPIs) are commonly prescribed medications for the management of acid-related gastrointestinal disorders.

Tim J. Knobbe and colleagues aimed to investigate the potential association between PPI use and fatigue as well as health-related quality of life among 937 kidney transplant recipients. Participants were at least one-year post-transplantation and were enrolled in the TransplantLines Biobank and Cohort Study.


Comment so far

Leave a reply